07 Jan 2001

Becozyme c - España

Updated: 07 Jan 2001

Becozyme c forte 30 grageas

Profilaxis de estados carenciales de vitaminas del grupo B y vitamina C: Restricciones dietéticas, malabsorción, tratamiento.

Becozyme c Description, Presentation and Dosage

Becozyme c Description

Becozyme c Drug Class Description

Complejo b, otras asociaciones

Becozyme c Drug Description

GRAGEAS

Becozyme c Presentation

Becozyme c Presentation

Dosis usual: 1-3 grageas al día.

Becozyme c Manufacturer

ROCHE

Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Becozyme c Dosage

Becozyme c Precautions, Reactions and Contraindications

Becozyme c Special Precautions

Related Drugs - Gastroenterologia

Back to top